Company / SG&A Expense
MESA LABORATORIES INC /CO/ SG&A Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$78.7M
FY2025
5-year range
$45.8M / $78.7M
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $46M to $79M over the past 2 years.
Based on SEC 10-K filings.
$79M in FY2025 with a 5-year CAGR of +11.4%.
Increased from $46M to $79M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- +11.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 7.3% year-over-year.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.03 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $78.7M | +7.3% |
| FY2024 | $73.3M | +60.2% |
| FY2023 | $45.8M | -36.8% |
| FY2022 | $72.4M | +20.1% |
| FY2021 | $60.3M | +31.7% |
| FY2020 | $45.8M | +19.9% |
| FY2019 | $38.2M | +22.0% |
| FY2018 | $31.3M | +19.2% |
| FY2017 | $26.3M | +15.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026